Quincy House, Harvard University

Operator of online applications building software based in Tampa, Florida. The company's platform builds custom online forms that you can use to collect data including online payments, contact info and RSVPs and also to automate the workflows that build the database, backend and scripts of nonprofits, business owners, freelancers, event planners, marketers and various companies, making collecting and understanding the data hassle-free.

Repsol S.A. is a Spanish multinational energy company that specializes in oil and gas exploration, production, refining, and petrochemicals. Established in 1986, Repsol has a rich history that dates back to 1927 through its predecessor entities. The company operates as a global integrated player, with a presence in over 90 countries and a workforce of 24,000 employees. Repsol produces approximately 571,000 barrels of oil equivalent per day and serves around 24 million customers. Repsol's operations span the entire energy value chain. In the upstream segment, the company focuses on oil and gas discovery and extraction, with significant offshore fields in various regions. The downstream segment includes refining, marketing, and distribution, where Repsol refines a large portion of Spain's crude oil and operates an extensive network of service stations. Additionally, Repsol is committed to energy transition initiatives, emphasizing responsible production and innovation in energy generation and mobility services.

AstraZeneca is a global pharmaceutical company focused on the research, development, and commercialization of prescription medicines. With around 90,000 employees in 85 countries, the company aims to harness scientific advancements for the benefit of people and society. AstraZeneca operates in various functions, including Clinical Development, Regulatory Affairs, Finance, IT, and Manufacturing. The company specializes in three main therapeutic areas: oncology, respiratory, and immunology. In oncology, AstraZeneca is dedicated to developing innovative treatments that aim to redefine cancer care. In the respiratory and immunology sectors, the company works to improve outcomes for patients with asthma and COPD, as well as other immune-driven diseases. Additionally, AstraZeneca has expanded its focus on rare diseases through its acquisition of Alexion, enhancing its capabilities in this area. The company is committed to advancing science and creating impactful therapies across multiple health conditions.

Dana-Farber Cancer Institute is a prominent comprehensive cancer center located in Boston, Massachusetts. Founded in 1947 by Dr. Sidney Farber, it initially focused on pediatric leukemia and has since expanded to provide care for patients of all ages. The institute is a principal teaching affiliate of Harvard Medical School and is recognized as one of the top cancer hospitals in the U.S., designated as a National Cancer Institute comprehensive cancer center. Dana-Farber offers a wide range of cancer care services, including clinical treatment, research, nutrition, social work, and counseling. It specializes in various cancers, including breast, gastrointestinal, and neuro-oncology, and is known for its extensive Pediatric Brain Tumor Program and the nation's oldest bone marrow transplantation program. The institute collaborates closely with Boston Children's Hospital and other medical centers to enhance patient care and advance research in areas such as genetics, immunotherapy, and personalized medicine.